Sera Prognostics (SERA) EBIT Margin (2020 - 2026)
Sera Prognostics (SERA) reported EBIT Margin of 66857.14% for Q1 2026, down 4251504.0% on a YoY basis from N/an in Q1 2025, and up 25.33% quarter-over-quarter from 89540.0% in Q4 2025.
Sera Prognostics (SERA) EBIT Margin (2020 - 2026) Analysis & Trends
Sera Prognostics has reported EBIT Margin for 7 years, with the latest figure at 66857.14% in Q1 2026.
- For the quarter ending Q1 2026, EBIT Margin fell 4251504.0% year-over-year to 66857.14%; the trailing twelve-month figure through Mar 2026 stood at 64235.09% (down 3224552.0% YoY), and the FY2025 full-year result was 45066.67%, up 251126.0% from the prior year.
- EBIT Margin for Q1 2026 stood at 66857.14%, up from 89540.0% in the prior quarter.
- The five-year high for EBIT Margin was 9317.07% in Q2 2023, with the low at 89540.0% in Q4 2025.
- Historically, EBIT Margin has averaged 33630.64% across 5 years, with a median of 27450.36% in 2024.
- Annual changes were most pronounced in 2022 — EBIT Margin surged 3223000 bps — and 2025, when it sank 5027750 bps.
- Sera Prognostics' EBIT Margin stood at 16027.69% in 2022, then plunged by 35 bps to 21580.49% in 2023, then tumbled by 82 bps to 39262.5% in 2024, then slumped by 128 bps to 89540.0% in 2025, then climbed by 25 bps to 66857.14% in 2026.
- The last three EBIT Margin figures came in at 66857.14% (Q1 2026), 89540.0% (Q4 2025), and 56125.0% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 16.24% |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 28.97% |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 10.04% |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 6.17% |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 21.42% |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 19.94% |
| 10 | Sera Prognostics | 100.52 Mn | 100.52 Mn | -28,000.00 | -66,857.14% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -66,857.14% |
| Dec 31, 2025 | -89,540.00% |
| Sep 30, 2025 | -56,125.00% |
| Jun 30, 2025 | -54,823.53% |
| Mar 31, 2025 | -24,342.11% |
| Dec 31, 2024 | -39,262.50% |
| Sep 30, 2024 | -30,558.62% |
| Jun 30, 2024 | -38,554.17% |
| Dec 31, 2023 | -21,580.49% |
| Sep 30, 2023 | -19,485.71% |
| Jun 30, 2023 | -9,317.07% |
| Mar 31, 2023 | -11,329.00% |
| Dec 31, 2022 | -16,027.69% |
| Sep 30, 2022 | -12,859.77% |
| Jun 30, 2022 | -15,058.97% |
| Mar 31, 2022 | -32,368.42% |
| Dec 31, 2021 | -48,257.69% |
| Sep 30, 2021 | -41,052.17% |
| Jun 30, 2021 | -36,905.00% |
| Mar 31, 2021 | -46,346.15% |